Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Wednesday newspaper round-up: Avon, AstraZeneca, Google
(Sharecast News) - Anti-sewage campaigners have warned of "extreme anger" if the Labour government does not radically reform the water regulator. Sources at the Environment Agency (EA) and in the Labour party have told the Guardian that while Labour had spent time considering reforms of the EA and Ofwat in order to fix the sewage crisis, some stricter options that had been proposed were now off the table. -Guardian The owner of the beauty brand Avon in the UK, Europe and Latin America has filed for bankruptcy as it tries to off-load more than $1bn of debt, including millions of dollars in liabilities linked to lawsuits alleging that talc in its products caused cancer. Avon Products Inc (API), a subsidiary of Brazil's Natura which bought Avon's non-North American trading businesses in 2020, has filed for Chapter 11, the American version of administration. - Guardian
AstraZeneca has become Britain's first £200bn company following a 20pc rally in its share price since the start of the year. Shares in the pharmaceutical business rose 1.1pc yesterday to value the company at £200.3bn. AstraZeneca's stock has surged so far this year amid strong sales of its roster of cancer and rare disease medicines. The drug company jumped ahead of Shell in April to become the most valuable business on the FTSE 100. - Telegraph
A growing number of people have cut corners on their travel insurance since the start of the cost of living crisis, research suggests. Some withhold information to obtain cheaper cover, while others are selective about the medical information that they declare, according to AllClear Travel Insurance. - The Times
Google could be ordered to break up its operations after a judge ruled that the company has an illegal monopoly over online search, according to a report. The US Department of Justice is considering ordering Alphabet, Google's owner, to divest parts of the search business, which could include the Android operating system and Google's web browser Chrome, Bloomberg reported. - The Times
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Doing Business with Fidelity | Diversity, Equity & Inclusion Reports | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.
